China Biotech In Review: Novartis Has A Novel Scandal Potentially Brewing

Home › China Biotech In Review: Novartis Has A Novel Scandal Potentially Brewing

Tianjin CanSino Biotech received a $10 million strategic investment from Lilly Asia Ventures, a venture capital arm of Lilly .

05.07	Atlantic Tropical Weather Outlook
05.07	Eastern North Pacific Tropical Weather Outlook
04.07	Hurricane Beryl Graphics
04.07	Hurricane Beryl Forecast Discussion Number 25
04.07	Hurricane Beryl Public Advisory Number 25
04.07	Summary for Hurricane Beryl (AT2/AL022024)
04.07	Hurricane Beryl Wind Speed Probabilities Number 25
04.07	Hurricane Beryl Forecast Advisory Number 25
More »

je.st